In the labyrinth of human biology, some of the most surprising discoveries emerge from the smallest players. A new study from Tufts University School of Medicine and the Tufts Graduate School of Biomedical Sciences sheds light on a novel connection between the gut–brain axis — specifically, how a common gut fungus, Candida albicans, may influence our relationship with alcohol.

Published on October 16 in the journal mBio, the study explores how this seemingly benign fungus, when overgrown in the gut, can disrupt the brain’s dopamine reward system — potentially altering behavior related to alcohol consumption. The research was conducted in mice, but its implications open the door to new understandings of Alcohol Use Disorder (AUD), a condition affecting over 5% of adults globally.

A Fungus with Unexpected Influence

Candida albicans is a normal resident of the human gut microbiome, usually kept in check by other microbes and a healthy immune system. However, under certain conditions — like poor diet, antibiotic use, or frequent alcohol consumption — it can overgrow, triggering a cascade of effects.

The researchers focused on the role of PGE₂ (prostaglandin E₂), a multifunctional molecule involved in inflammation, fever, and digestive regulation. As C. albicans blooms in the gut, it stimulates the production of PGE₂, which is capable of crossing the blood–brain barrier (BBB).

Crossing from Gut to Brain

Once in the brain, PGE₂ molecules appear to alter dopamine signaling in the dorsal striatum, a region associated with reward, motivation, and habit formation. Dopamine is a key neurotransmitter in addiction science — it’s the chemical that makes us feel good when we eat chocolate, win a game, or, in many cases, drink alcohol.

Dopamine Pathways. In the brain, dopamine plays an important role in the regulation of reward and movement. As part of the reward pathway, dopamine is manufactured in nerve cell bodies located within the ventral tegmental area (VTA) and is released in the nucleus accumbens and the prefrontal cortex. Its motor functions are linked to a separate pathway, with cell bodies in the substantia nigra that manufacture and release dopamine into the striatum.
**Source:** Wikimedia Commons, CC BY-SA 3.0

The team hypothesized that fungal-induced PGE₂ would increase alcohol-seeking behavior, making the beverage more rewarding to the mice.
They were wrong.

Instead of showing increased interest in alcohol, mice with a C. albicans overgrowth began avoiding it. Despite being exposed to alcohol regularly, their preference shifted away from it, defying expectations. Blocking PGE₂ receptors reversed this aversion, restoring alcohol consumption.

A Lesson in Scientific Curiosity

“Our study shows how science works — our initial ideas were very wrong,” said Andrew Day, lead author and former Ph.D. student at Tufts. “This could be explained by differences in how mice respond to C. albicans compared to humans, differences in fungal strains, or we might be seeing a small snapshot of the entire story.”

More Than Just Preference

The effects weren’t limited to preference. The study also found that mice with fungal overgrowth were more sensitive to alcohol’s impact on motor coordination — essentially, they became more easily impaired. Again, this effect was linked to PGE₂ and could be reversed when its activity was blocked.

This dual finding — behavioral aversion and increased motor sensitivity — paints a broader picture of how gut microbes might influence not just our cravings but also our physical responses to substances like alcohol.

Implications for Alcohol Use Disorder

Alcohol use disorder is a deeply complex condition. It’s not simply about willpower or choice. Genetics, neurochemistry, trauma, environment, and now — possibly — the gut microbiome, all play a role.

Traditional treatments such as cognitive behavioral therapy, support groups, medications, and lifestyle changes have helped many. Yet relapse rates remain high, and not all individuals respond to these interventions. That’s why researchers are increasingly exploring the gut-brain axis as a potential new frontier.

The Tufts study aligns with recent clinical interest in fecal microbiota transplantation (FMT) as a treatment for alcohol use disorder. Preliminary human studies suggest that altering the microbial landscape of the gut can affect alcohol consumption behaviors. Fungi like C. albicans may be key players in this process.

The Power of Inflammation

The study’s focus on PGE₂ underscores the central role that inflammation may play in addiction pathways. Unlike bacterial toxins or immune cell responses, PGE₂ is a subtle but influential molecule. It can modulate pain, behavior, and now — it seems — alcohol response.

Blocking its activity reversed both the behavioral and motor effects in the study’s mice. This raises the possibility of future drug development aimed at modulating PGE₂ pathways as a treatment for alcohol dependence.

It also presents a cautionary tale. The microbiome is a delicate ecosystem, and shifts in its fungal components can have neurochemical consequences. As we continue to explore its influence, it’s crucial to understand not just which species are present, but how they interact with the host.

Where Do We Go From Here?

The connection between gut fungi and alcohol behavior is still in its early days. This study is one piece of a much larger puzzle, but it’s a compelling one. It invites further investigation into:

How C. albicans overgrowth occurs in humans with alcohol use disorder
Whether PGE₂ plays a similar role in the human brain
How fungal strains differ in their ability to affect host behavior
What treatments might modulate fungal activity or inflammatory signaling

As researchers continue to trace the fine threads between gut and brain, it becomes increasingly clear that addiction is not simply a mental health issue — it is a whole-body condition.
And sometimes, the smallest organisms may be the loudest voices in that conversation.